BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 24345162)

  • 1. Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2.
    Vandal M; Alata W; Tremblay C; Rioux-Perreault C; Salem N; Calon F; Plourde M
    J Neurochem; 2014 May; 129(3):516-26. PubMed ID: 24345162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol.
    Kariv-Inbal Z; Yacobson S; Berkecz R; Peter M; Janaky T; Lütjohann D; Broersen LM; Hartmann T; Michaelson DM
    J Alzheimers Dis; 2012; 28(3):667-83. PubMed ID: 22057027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
    Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
    Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the plasma-liver-brain axis of omega-3 fatty acid metabolism in mouse knock-in for the human apolipoprotein E epsilon 4 allele.
    Husain MA; Vachon A; Chouinard-Watkins R; Vandal M; Calon F; Plourde M
    J Nutr Biochem; 2023 Jan; 111():109181. PubMed ID: 36220526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Diet Rich in Docosahexaenoic Acid Restores Liver Arachidonic Acid and Docosahexaenoic Acid Concentrations in Mice Homozygous for the Human Apolipoprotein E ε4 Allele.
    Chouinard-Watkins R; Pinçon A; Coulombe JD; Spencer R; Massenavette L; Plourde M
    J Nutr; 2016 Jul; 146(7):1315-21. PubMed ID: 27306896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase.
    Woody SK; Zhou H; Ibrahimi S; Dong Y; Zhao L
    J Alzheimers Dis; 2016 Jun; 53(3):1015-31. PubMed ID: 27340853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human apolipoprotein E ɛ4 expression impairs cerebral vascularization and blood-brain barrier function in mice.
    Alata W; Ye Y; St-Amour I; Vandal M; Calon F
    J Cereb Blood Flow Metab; 2015 Jan; 35(1):86-94. PubMed ID: 25335802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
    Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
    J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral phenotype and BDNF differences related to apoE isoforms and sex in young transgenic mice.
    Reverte I; Klein AB; Ratner C; Domingo JL; Colomina MT
    Exp Neurol; 2012 Sep; 237(1):116-25. PubMed ID: 22735491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
    Aleshkov S; Abraham CR; Zannis VI
    Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E isoforms disrupt long-chain fatty acid distribution in the plasma, the liver and the adipose tissue of mice.
    Conway V; Larouche A; Alata W; Vandal M; Calon F; Plourde M
    Prostaglandins Leukot Essent Fatty Acids; 2014 Dec; 91(6):261-7. PubMed ID: 25301204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy.
    Williams T; Bathe T; Vo Q; Sacilotto P; McFarland K; Ruiz AJ; Hery GP; Sullivan P; Borchelt DR; Prokop S; Chakrabarty P
    Acta Neuropathol Commun; 2023 Jun; 11(1):99. PubMed ID: 37337279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Apolipoprotein E Genotype Differentially Affects Olfactory Behavior and Sensory Physiology in Mice.
    East BS; Fleming G; Peng K; Olofsson JK; Levy E; Mathews PM; Wilson DA
    Neuroscience; 2018 Jun; 380():103-110. PubMed ID: 29678753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of APOE genotype on Alzheimer's disease risk is influenced by sex and docosahexaenoic acid status.
    Pontifex M; Vauzour D; Minihane AM
    Neurobiol Aging; 2018 Sep; 69():209-220. PubMed ID: 29909178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DHA brain uptake and APOE4 status: a PET study with [1-
    Yassine HN; Croteau E; Rawat V; Hibbeln JR; Rapoport SI; Cunnane SC; Umhau JC
    Alzheimers Res Ther; 2017 Mar; 9(1):23. PubMed ID: 28335828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer's disease.
    Patrick RP
    FASEB J; 2019 Feb; 33(2):1554-1564. PubMed ID: 30289748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status.
    Reas ET; Triebswetter C; Banks SJ; McEvoy LK
    Alzheimers Res Ther; 2024 Jan; 16(1):7. PubMed ID: 38212861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of DHA on cognitive dysfunction in aging and Alzheimer's disease: The mediating roles of ApoE.
    Zhang X; Yuan T; Chen X; Liu X; Hu J; Liu Z
    Prog Lipid Res; 2024 Jan; 93():101256. PubMed ID: 37890592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attentional performance, impulsivity, and related neurotransmitter systems in apoE2, apoE3, and apoE4 female transgenic mice.
    Reverte I; Peris-Sampedro F; Basaure P; Campa L; Suñol C; Moreno M; Domingo JL; Colomina MT
    Psychopharmacology (Berl); 2016 Jan; 233(2):295-308. PubMed ID: 26497539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.